Follow Us 
Clinical Cancer Details
| Protocol No.: | CTSUECOG1302 | ||||
| Title: | A Randomized Phase III Trial, placebo controlled, of docetaxel versus docetaxel plus ZD1839 in performance status 2 or previously treated patients with recurrent or Metastatic head and neck cancer. | ||||
| Staging: | Stage 4/Metastatic, | ||||
| Objective: | |||||
| Overview: | This study is comparing a standard drug with or without a new drug, IRESSA, for patients with head and neck cancer that has spread. | ||||
| Eligibility Requirements: |
|
||||
| Contact: |
Regional Oncology Center 303 N. Clyde Morris Blvd., Daytona Beach, Florida 32114 Debbie Reynolds, RN, OCN (386) 254-4213 Regional Oncology Center 303 N. Clyde Morris Blvd., Daytona Beach, Florida 32114 Beverly Shook (386) 254-4213 |
